Darunavir 600 mg
Developed as a second-generation protease inhibitor, Darunavir 600 mg Tablets are used in boosted antiretroviral regimens to manage HIV-1 infection, particularly in patients requiring protease inhibitor–based therapy under recommended treatment frameworks.
Product Details
Therapeutic Class
Protease Inhibitor (Antiretroviral)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
600 mg administered with a pharmacokinetic booster (such as ritonavir) and in combination with other antiretroviral agents, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
60 tablets